Press release from Companies: Third Quarter Report Q3-2023

Press release from Companies: Cessatech announces that the Paediatric Committee has agreed to a 50% reduction of the required number of patients in the final study of its nasal spray for the treatment of acute pain in children

Press release from Companies: Cessatech announces last participant dosed in pivotal trial 0205 with lead candidate CT001

Press release from Companies: Cessatech announces agreement with the European Medicines Agency on a Paediatric Investigational Plan for its second asset CT002 for medical procedural sedation in children

Press release from Companies: Second quarter report Q2-2023

Press release from Companies: Cessatech secures DKK 5 million loan facility agreement to support the US launch of its lead program CT001

Press release from Companies: Cessatech - Ventis Pharma US partnership - Q&A

Press release from Companies: Cessatech and Ventis Pharma announce US partnership for CT001

Press release from Companies: Cessatech provides positive news regarding shelf life of CT001

Press release from Companies: First quarter report Q1-2023

Press release from Companies: April business update - the business strategy

Press release from Companies: Minutes from the Annual General Meeting in Cessatech A/S